<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01862952</url>
  </required_header>
  <id_info>
    <org_study_id>EC/2013/211</org_study_id>
    <nct_id>NCT01862952</nct_id>
  </id_info>
  <brief_title>Continuous Video- EEG Monitoring in the Acute Phase in Patients With a Cerebrovascular Attack- Randomisation of a Subpopulation Regarding Treatment Strategy</brief_title>
  <acronym>Video-EEG</acronym>
  <official_title>Continuous Video- EEG Monitoring in the Acute Phase in Patients With a Cerebrovascular Attack- Randomisation of a Subpopulation Regarding Treatment Strategy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke is a major cause of epilepsy. The pathophysiological mechanisms of poststroke epilepsy
      are not known. Subclinical epileptiform discharges could contribute to the neuronal damage
      and influence functional outcome. Electro-encefalography (EEG) is the golden standard to
      detect interictal, ictal and subclinical epileptic brain activity.

      Patients admitted to the stroke unit with an ischemic or hemorrhagic cerebrovascular attack
      will undergo a 24 hours video-EEG monitoring to detect epileptiform discharges. Clinical and
      paraclinical (imaging, serum markers of neuronal damage) parameters will be analysed together
      with the EEG results. The EEG results will be correlated with the occurence of epileptic
      seizures and functional outcome and mortality in the acute phase and in the long-term. When
      subclinical epileptic discharges are found on the EEG, patients will be asked to participate
      in a second part of the study where they will be randomised into a treatment (with an
      anti-epileptic drug) versus no-treatment group for a period of 6 months. Outcome parameters
      will be the occurrence of epileptic seizures, mortality and functional outcome.

      Our main hypothesis is that the occurrence of subclinical epileptiform discharges during the
      acute phase following stroke influences functional outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>day 7</time_frame>
    <description>Modified ranking scale and NIHSS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>at month 6</time_frame>
    <description>Modified ranking scale and NIHSS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>at month 6</time_frame>
    <description>medical records, seizure diary, interrogation of patient and caregiver</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of epileptic seizures</measure>
    <time_frame>at month 6</time_frame>
    <description>medical records, seizure diary, interrogation of patient and caregiver</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>antiepileptic treatment as used in daily clinical practice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Antiepileptic treatment as used in daily clinical practice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No medication</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>starting of anti-epileptic drug treatment</intervention_name>
    <arm_group_label>antiepileptic treatment as used in daily clinical practice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ischemic arteria cerebri media infarct and spontaneous intraparenchymal
             bleeding

        Exclusion Criteria:

          -  Patients with subarachnoidal haemorrhage, traumatic haemorrhage (epidural/subdural
             bleeding), cerebral venous sinus thrombosis, epilepsy, anti-epileptic treatment,
             transient ischemic attack, indication for urgent neurosurgical intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Veerle De Herdt, MD, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ghent University Hospital, Department of Neurology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veerle De Herdt, MD, Phd</last_name>
    <email>Veerle.deherdt@ugent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veerle De Herdt, MD, Phd</last_name>
    </contact>
    <contact_backup>
      <last_name>Dimitri Hemelsoet, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Veerle De Herdt, MD, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2013</study_first_submitted>
  <study_first_submitted_qc>May 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2013</study_first_posted>
  <last_update_submitted>October 12, 2017</last_update_submitted>
  <last_update_submitted_qc>October 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anticonvulsants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

